Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice

Journal of Steroid Biochemistry and Molecular Biology

Volumn 111, Issue 3-5, 2008, Pages 200-207

  Luchetti, C G ^a,b   Miko E ^c   Szekeres Bartho, J ^c   Paz, D A ^b   Motta, A B ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cytokines; Dehydroepiandrosterone; Metformin; PIBF; Pregnancy; Progesterone

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; METFORMIN; PLACENTA PROTEIN; PRASTERONE; PROGESTERONE; PROGESTERONE INDUCED BLOCKING FACTOR PROTEIN; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOCKING FACTOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EMBRYO RESORPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; CYCLOOXYGENASE 2; CYTOKINES; DEHYDROEPIANDROSTERONE; EMBRYO IMPLANTATION; EMBRYO LOSS; EMBRYO, MAMMALIAN; FEMALE; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MICE; MICE, INBRED BALB C; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY, ANIMAL; SUPPRESSOR FACTORS, IMMUNOLOGIC;

ANIMALIA; MUS;

EID: 49449088261     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.06.007     Document Type: Article

References (51)

1. Clark D.A., and Croitoru K. TH1/TH2, 3 imbalance due to cytokine producing NK, gamma delta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy. Am. J. Reprod. Immunol. 45 5 (2001) 257-265
2. Lim K.J.L., Odukoya O.A., Ajjan R.A., Li T.C., Weetman A.P., and Cooke I.D. Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol. Hum. Reprod. 4 1 (1998) 77-81
3. Gutiérrez G., Malan Borel I., and Margni R.A. The placental regulatory factor involved in the asymmetric IgG antibody synthesis responds to IL-6 features. J. Reprod. Immunol. 49 1 (2001) 21-32
4. Szekeres-Bartho J., Reznikoff-Etievant M.F., Varga P., Pichon M.F., Varga Z., and Chaouat G. Lymphocytic progesterone receptors in normal and pathological human pregnancy. J. Reprod. Immunol. 16 3 (1989) 239-247
5. J. Szekeres-Bartho, B. Polgár, N. Kozma, E. Miko, G. Par, L. Szereday, A. Barakonyi, T. Palkovics, O. Papp, P. Varga, Progesterone-dependent immunomodulation, Chem. Immunol. Allergy 89 (2005) 118-125.
6. Szekeres-Barthó J., Par G., Szereday L., Smart C.Y., and Achacz I. Progesterone and non-specific immunological mechanisms in pregnancy. Am. J. Reprod. Immunol. 38 3 (1997) 176-182
7. Polgár B., Nagy E., Mikó E., Varga P., and Szekeres-Barthó J. Urinary PIBF (progesterone-induced blocking factor) concentration is related to pregnancy outcome. Biol. Reprod. 71 5 (2004) 1699-1705
8. Szekeres-Barthó J., and Wegmann T.G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 31 1/2 (1996) 81-95
9. Szereday L., Varga P., and Szekeres-Barthó J. Cytokine production in pregnancy. Am. J. Reprod. Immunol. 38 6 (1997) 418-422
10. Nieschlag E., Loriaux D.L., Ruder H.J., Zucker I.R., Kirschner M.A., and Lipsett M.B. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J. Endocrinol. 57 1 (1973) 123-134
11. Tagawa N., Hidaka Y., Takano T., Shimaoka Y., Kobayashi Y., and Amino N. Serum concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate and their relation to cytokine production during and after normal pregnancy. Steroids 69 10 (2004) 675-680
12. Miki Y., Nakata T., Suzuki T., Damel A.D., Moriya T., Kaneko C., Hidaka K., Shiotsu Y., Kusaka H., and Sasano H. Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J. Clin. Endocrinol. Metab. 87 12 (2002) 5760-5768
13. Du C., Guan Q., Khalil M., and Siram S. Stimulation of Th2 response by high doses of dehydroepiandrosterone in KLH-primed splenocytes. Exp. Biol. Med. 226 11 (2001) 1051-1060
14. Powell J.M., and Sonnenfeld G. The effects of dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. J. Interferon Cytokine Res. 26 1 (2006) 34-39
15. Okon M.A., Laird S.M., Tuckerman E.M., and Li T.C. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil. Steril. 69 4 (1998) 682-690
16. Sir-Petermann T., Maliqueo M., Angel B., Lara H.E., Perez-Bravo F., and Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovary syndrome: possible implications in prenatal androgenization. Hum. Reprod. 17 10 (2002) 2573-2579
17. Tuckerman E.M., Okon M.A., Li T., and Laird S.M. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil. Steril. 74 4 (2000) 771-779
18. Sander V., Solano M.E., Gutierrez M., Luchetti C.G., Rearte M.B., Gonzalez C., Di Girolamo G., and Motta A.B. The influence of dehydroepiandrosterone on early pregnancy in mice. Neuroimmunomodulation 12 5 (2005) 285-292
19. Solano M.E., Elia E., Luchetti C.G., Sander V., Di Girolamo G., Gonzalez C., and Motta A.B. Metformin prevents embryonic resorption induced by hyperandrogenization with dehydroepiandrosterone in mice. Reprod. Fertil. Dev. 18 5 (2006) 533-544
20. Abbot D.H., Dumesic D., Eisner J.R., Colman R.J., and Kenmitz J.W. Insights into the development of PCOS from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol. Metab. 9 2 (1998) 62-67
21. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85 7 (2000) 2434-2438
22. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 333 13 (1995) 853-861
23. Balen A.H., Tan S.L., McDougall J., and Jacobs H.S. Miscarriage rates following in-vitro fertilizat are increased in women with polycystic ovary syndrome and reduced by pituitary desensitization with buserelin. Hum. Reprod. 8 6 (1993) 959-964
24. Sagle M., Bishop K., Ridley N., Alexander F.M., Michel M., Bonney R.C., Beard R.W., and Franks S. Recurrent early miscarriage and polycystic ovaries. Br. Med. J. 297 6655 (1988) 1027-1028
25. Glueck C.J., Wang P., Goldenberg N., and Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum. Reprod. 17 (2002) 2858-2864
26. Mahesh V.B., and Greenblatt R.B. Isolation of dehydroepiandrosterone and 17-hydroxy-pregnenolone from polycystic ovaries of the Stein-Leventhal syndrome. J. Clin. Endocrinol. Metab. 22 (1962) 441-448
27. Roy S., Mahesh V.B., and Greenblatt R.B. Effect of dehydroepiandrosterone and androstenedione on the reproductive organs of female rats; production of cystic changes in the ovary. Nature 196 (1962) 2-6
28. Lee M.T., Anderson E., and Lee G.Y. Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. Anat. Rec. 231 2 (1991) 185-192
29. Henmi H., Endo T., Nagasawa K., Hayashi T., Chida M., Akutagawa N., Iwasaki M., Kitajima Y., Kiya T., Nishikawa A., Manase K., and Rudo R. Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol. Reprod. 64 1 (2001) 157-162
30. Luchetti C.G., Solano M.E., Sander V., Barreiro-Arcos M.L., Gonzalez C., Di Girolamo G., Chiocchio S., Cremaschi G., and Motta A.B. Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function. J. Reprod. Immunol. 64 1/2 (2004) 59-74
31. Stumvoll M., Nurjhan N., Perriello G., Dailey G., and Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333 9 (1995) 550-554
32. Hundal R.S., Krssak M., Dufour M.S., Laurent D., Lebon V., Chandramouli V., Inzucchi S.E., Schumann W.C., Petersen K.F., Landau B.R., and Shulman G.I. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49 12 (2000) 2063-2069
33. Fryer L.G.D., Parbu-Patel A., and Carling D. The anti-diabetic drugs roziglitazone and metformin stimulate AMP-activated protein kinase through distinct signalling pathways. J. Biol. Chem. 277 28 (2002) 25226-25232
34. Elia E., Sander V., Luchetti C.G., Solano M.E., Di Girolamo G., Gonzalez C., and Motta A.B. The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Mol. Hum. Reprod. 12 8 (2006) 475-481
35. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 8 (2001) 1167-1174
36. Fedorcsak P., Dale P.O., Storeng R., Abyholm T., and Tanbo T. The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecol. Endocrinol. 17 3 (2003) 207-214
37. Harborne L., Fleming R., Lyall H., Sattar N., and Norman J. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88 9 (2003) 4116-4123
38. Diamanti-Kandarakis E., Kouli C., Tsianateli T., and Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur. J. Endocrinol. 138 3 (1998) 269-274
39. Ehrmann D.A., Cavaghan M.K., Imperial J., Rosenfield R.L., and Polonsky K.S. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82 2 (1997) 524-530
40. Glueck C.J., Fontaine R.N., Wang P., Subbiah M.T., Weber K., Illig E., Streicher P., Sieve-Smith L., Tracy T.M., Lang J.E., and McCullough P. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 50 7 (2001) 856-861
41. Ia Marca A., Morgante G., Palumbo M., Cianci A., Petraglia F., and De Leo V. Insulin-lowering treatment reduces aromatase activity in response to follicle stimulating hormone in women with polycystic ovary syndrome. Fertil. Steril. 78 6 (2002) 1234-1249
42. Negri P.C.C., Tosi F., Perrone M., Caputo E., Zanolin M., and Muggeo M. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month tial, followed by open, long-term clinical evaluation. J. Clin. Endocrinol. Metab. 85 1 (2000) 139-146
43. Nestler J.E., and Jakubowicz D.J. Decreases in ovarian cytochrome P450c17{alpha} activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N. Engl. J. Med. 335 9 (1996) 617-623
44. Jakubowicz D.J., Seppala M., Jakubowicz S., Rodríguez-Armas O., Rivas-Santiago A., Koistinen H., Koistinen R., and Nestler J. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J. Clin. Endocrin. Metab. 86 3 (2001) 1126-1133
45. Velazquez E., Acosta A., and Mendoza S.G. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol. 90 3 (1997) 392-395
46. Glueck C.J., Wang P., Goldenberg N., and Stieve-Smith L. Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin. Clin. Appl. Thromb. Hemost. 10 4 (2004) 323-334
47. Khattab S., Mohsen I.A., Foutouh I.A., Ramadan A., Moaz M., and Al-Inany H. Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol. Endocrinol. 22 12 (2006) 680-684
48. Kozma N., Halasz M., Polgár P., Poehlmann T.G., Markert U.R., Palkovics T., Keszei M., Par G., Kiss K., Szeberenyi J., Grama L., and Szekeres-Bartho J. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J. Immunol. 176 2 (2006) 819-826
49. Blois S., Zenclussen A.C., Roux M.E., Olmos S., di Conza J., Arck P.C., and Margni R.A. Asymmetric antibodies 245 es (AAb) in the female reproductive
50. Palomba S., Russo T., Orio F., Falbo A., Manguso F., Cascella T., Tolino A., Carmina E., Colao A., and Zullo F. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum. Reprod. 21 11 (2006) 2823-2829
51. Germain S.J., Sacks G.P., Soorana S.R., Sargent I.L., and Redman C.W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol. 178 9 (2007) 5949-5956